In the absence of evidence of IgE-mediated sensitization, VIT should not be performed, except in patients at high risk of severe anaphylaxis (especially mastocytosis, cardiovascular or respiratory arrest in previous anaphylaxis). The gene discussed is IGHE; the disease is anaphylaxis.